Foghorn Therapeutics Inc. (FHTX) Earnings
|
Expand Research on FHTX
| Next EPS Date | 8/11/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.25 | N/A | N/A | $7.59M | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | -$0.29 | -$0.28 | -$0.01 | $3.26M | $9.35M | N/A |  | | Details | |
| 3/11/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 3/5/26 |
Q425 | N/A | -$0.25 | N/A | N/A | $9.49M | N/A | N/A | N/A | ||
| 11/11/25 |
Q325 | N/A | -$0.33 | N/A | N/A | $5.86M | N/A | N/A | N/A |
